Nimmerjahn F - Search Results

1

B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS.

Comabella M, Montalban X, Kakalacheva K, Osman D, Nimmerjahn F, Tintoré M, Lünemann JD. Comabella M, et al. Among authors: nimmerjahn f. J Neuroimmunol. 2010 Jun;223(1-2):135-7. doi: 10.1016/j.jneuroim.2010.03.015. J Neuroimmunol. 2010. PMID: 20399509

2

Impaired inhibitory Fcgamma receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy.

Tackenberg B, Jelcic I, Baerenwaldt A, Oertel WH, Sommer N, Nimmerjahn F, Lünemann JD. Tackenberg B, et al. Among authors: nimmerjahn f. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4788-92. doi: 10.1073/pnas.0807319106. Epub 2009 Mar 4. Proc Natl Acad Sci U S A. 2009. PMID: 19261857 Free PMC article.

3

Mechanisms of IVIG efficacy in chronic inflammatory demyelinating polyneuropathy.

Tackenberg B, Nimmerjahn F, Lünemann JD. Tackenberg B, et al. Among authors: nimmerjahn f. J Clin Immunol. 2010 May;30 Suppl 1:S65-9. doi: 10.1007/s10875-010-9398-1. J Clin Immunol. 2010. PMID: 20424898 Review.

4

Expression and function of the inhibitory Fcγ-receptor in CIDP.

Nimmerjahn F, Lünemann JD. Nimmerjahn F, et al. J Peripher Nerv Syst. 2011 Jun;16 Suppl 1:41-4. doi: 10.1111/j.1529-8027.2011.00305.x. J Peripher Nerv Syst. 2011. PMID: 21696497

5

Intravenous immunoglobulin in neurology--mode of action and clinical efficacy.

Lünemann JD, Nimmerjahn F, Dalakas MC. Lünemann JD, et al. Among authors: nimmerjahn f. Nat Rev Neurol. 2015 Feb;11(2):80-9. doi: 10.1038/nrneurol.2014.253. Epub 2015 Jan 6. Nat Rev Neurol. 2015. PMID: 25561275 Review.

6

Deregulated Fcγ receptor expression in patients with CIDP.

Quast I, Cueni F, Nimmerjahn F, Tackenberg B, Lünemann JD. Quast I, et al. Among authors: nimmerjahn f. Neurol Neuroimmunol Neuroinflamm. 2015 Aug 20;2(5):e148. doi: 10.1212/NXI.0000000000000148. eCollection 2015 Oct. Neurol Neuroimmunol Neuroinflamm. 2015. PMID: 26380354 Free PMC article.

7

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity.

Quast I, Keller CW, Maurer MA, Giddens JP, Tackenberg B, Wang LX, Münz C, Nimmerjahn F, Dalakas MC, Lünemann JD. Quast I, et al. Among authors: nimmerjahn f. J Clin Invest. 2015 Nov 2;125(11):4160-70. doi: 10.1172/JCI82695. Epub 2015 Oct 5. J Clin Invest. 2015. PMID: 26436649 Free PMC article. Clinical Trial.

8

Impact of FcγR variants on the response to alemtuzumab in multiple sclerosis.

Keller CW, Ruck T, McHugh D, Pfeuffer S, Gross CC, Korsukewitz C, Melzer N, Klotz L, Meuth SG, Münz C, Nimmerjahn F, Wiendl H, Lünemann JD. Keller CW, et al. Among authors: nimmerjahn f. Ann Clin Transl Neurol. 2019 Dec;6(12):2586-2594. doi: 10.1002/acn3.50935. Epub 2019 Nov 4. Ann Clin Transl Neurol. 2019. PMID: 31682087 Free PMC article.

9

Next-generation antibody-based therapies in neurology.

Ruck T, Nimmerjahn F, Wiendl H, Lünemann JD. Ruck T, et al. Among authors: nimmerjahn f. Brain. 2022 May 24;145(4):1229-1241. doi: 10.1093/brain/awab465. Brain. 2022. PMID: 34928330 Free PMC article. Review.

10

Impaired B Cell Expression of the Inhibitory Fcγ Receptor IIB in Myasthenia Gravis.

Keller CW, Chuquisana O, Derdelinckx J, Gross CC, Berger K, Robinson J, Nimmerjahn F, Wiendl H, Willcox N, Lünemann JD. Keller CW, et al. Among authors: nimmerjahn f. Ann Neurol. 2022 Dec;92(6):1046-1051. doi: 10.1002/ana.26507. Epub 2022 Sep 27. Ann Neurol. 2022. PMID: 36094152

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

227 results

Search Page

Filters